The centralisation of urologic oncology care produces better results: that is the case made by Maria Laguna Pes in her inaugural lecture. This is because it allows us to ensure that each patient receives even better and tailor-made treatment.
Urology is seen as one of the smaller surgical specialties. However, the rise in life expectancy, patients’ changing expectations and the desire to maintain quality of life after treatment all mean that the importance of the specialty is set to increase in future. According to Laguna Pes we currently find ourselves at a crossroads, at a time when important changes are taking place in healthcare. Super-specialisation and the realisation that centralised care benefits patients play an important role here. If we want to implement these changes, all the parties involved will need to work together: physicians, insurers and patient interest groups. Apart from personal and institutional commitment, these changes also require a new way of approaching developments within health care, one that is centred around cooperation.
‘More is better’, argues Laguna Pes, in the sense that centralising procedures results in the optimalisation of treatment outcomes. This is particularly relevant to highly complex oncological procedures including treatments for prostate, kidney and bladder cancer. On the other hand, ‘less is more’: urology is a specialty that is strongly tied to technologies and the introduction of less invasive (organ-sparing) treatments has greatly increased preservation of quality of life.
M. Laguna Pes, professor of Urologic Oncology: Meer is Beter en Minder is Meer.
This event is open to the public.
(Please note: this inaugural lecture will be held in Dutch.)